Fig. 1From: A window of opportunity trial evaluating intratumoral injection of Copaxone® in patients with percutaneously accessible tumorsA Exemplary injection site reaction after subcutaneous Copaxone® injection. B GA precipitates as spherical particles at the injection site. C GA labeled with an infrared dye was injected into HNSCC orthotopic tumors in mice and tracked for 48 h. GA persisted in tumors > 2 days while injections of vehicles (4% mannitol) were nullBack to article page